Clinical trial
Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
NCT02101606 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
- Lead sponsor
- University of Alberta
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- November 30, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.